Market map: Meet the companies deploying AI agents in the outpatient setting
First, a disclaimer: No market map is fully exhaustive.
We focused our efforts on the companies deploying AI agents in the ambulatory or outpatient setting. These companies are generally also post-series A, as there has been an explosion of pre-seed and seed activity in the space. We also excluded vendors whose primary business model is selling into healthcare systems. Submissions came from a cross section of our network, inclusive of venture capital investors, operators, and founders (see the full list that contributed directly underneath the map).
To be fully transparent, we struggled a bit in the scribe category because, in some cases, the agents involve a roadmapping exercise, while others are live.
If your company fits the criteria and should be on the list, reach out to us before our next update!
|
Reserve Your Spot for Upcoming Webinars!
Want to support Second Opinion?
- 🌟 Leave a review for the Second Opinion Podcast
- 📧 Share this email with other friends in the healthcare space!
- 💵 Become a paid subscriber!
- 📢 Become a sponsor
Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
We're live at 11:30 ET: The Shift Left & the Impact of the Midterms on Healthcare
We're going live in a few minutes — 11:30 AM ET — with a same-day panel on what Tuesday'
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&